TargetMol

2-Furoic acid

Product Code:
 
TAR-T5544
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T5544-100mg100mg£103.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T5544-1mL1 mL * 10 mM (in DMSO)£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
2-Furoic acid, an orally active selective human cathepsin K inhibitor, may have the therapeutic potential for the treatment of diseases characterized by excessive bone loss including osteoporosis.Furan-2-carboxylic acid also has anti-bacterial effect.
CAS:
88-14-2
Formula:
C5H4O3
Molecular Weight:
112.084
Pathway:
Microbiology/Virology; Metabolism
Purity:
1
SMILES:
OC(=O)c1ccco1
Target:
Anti-infection; ATP Citrate Lyase; Endogenous Metabolite; Acyltransferase

References

Hara S, Isoda R, Tahvanainen T, et al. Trace Amounts of Furan-2-Carboxylic Acids Determine the Quality of Solid Agar Plates for Bacterial Culture[J]. Plos One, 2012, 7(7):e41142. Kim, M. K . An Orally Active Cathepsin K Inhibitor, Furan-2-Carboxylic Acid, 1-?-cyclohexyl)-amide (OST-4077), Inhibits Osteoclast Activity in Vitro and Bone Loss in Ovariectomized Rats[J]. Journal of Pharmacology and Experimental Therapeutics, 2006, 318(2):555-562.